Genetic test helps predict risk of prostate cancer recurrence
(Medical Xpress)—Prostate cancer ranks as the most common internal malignancy diagnosed in men in the United States, but often does not require extensive treatment.
May 10, 2013
0
0
(Medical Xpress)—Prostate cancer ranks as the most common internal malignancy diagnosed in men in the United States, but often does not require extensive treatment.
May 10, 2013
0
0
Preeclampsia is a condition that affects the placenta during pregnancy and is dangerous for both the fetus and the mother. Scientists from the Institut Pasteur, Inserm and the CNRS have proposed a new therapy, tested in two ...
Aug 30, 2022
0
2
On May 6, the "All of Us" study started enrolling participants. This national study will be one of the largest ever examining the connection between genetics, behavior and medical outcomes, with a goal of 1 million or more ...
May 21, 2018
0
1
An extensive database identifying immune traits, such as how immune cell function is regulated at the genetic level in healthy people, is reported by researchers from the National Institutes of Health (NIH) and their collaborators ...
Mar 12, 2015
0
3
Prostate cancer is often considered an elderly man's disease, and little is known about the approximately 2% of cases that arise in men who are aged 50 years or younger. Research published in the February 11th issue of the ...
Feb 11, 2013
0
0
By analysing samples from hundreds of Finns with diabetes, scientists have identified genes, and the proteins they encode, that could be involved in the development of diabetic kidney disease. The research, conducted by researchers ...
Mar 12, 2020
0
22
New research being presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD) in Hamburg (2–6 Oct) finds that cigarette smoking increases the risk of developing type 2 diabetes ...
Oct 3, 2023
0
2
Antibodies can be likened to keys, with antigens as the corresponding locks. Each antibody is uniquely shaped to fit a specific antigen, much like a key fits its particular lock. The precise ability to bind to disease-causing ...
Jun 25, 2024
0
28
An international effort led by researchers at the Perelman School of Medicine at the University of Pennsylvania has resulted in positive phase 3 clinical trial results for a new medicine to treat patients suffering from a ...
Nov 2, 2012
0
0
In an article revealed in Nature, scientists from deCODE Genetics, a subsidiary of the pharmaceutical company Amgen, demonstrated how plasma proteomics can contribute to a better understanding of diseases.
Oct 4, 2023
0
1